This session provides an update on diabetes mellitus and its related complications. Pathophysiology and pharmacotherapy relative to medical-surgical nursing practice is also shared, as well as information about the newer incretin-based therapies used in the treatment of DM.
Contact hours available until 9/29/2015.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure:
Speaker(s) have no disclosures to declare.
Planning Committee members have no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA).
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.
Objectives:
- Review physiology of glucose homeostasis.
- Review the diagnostic criteria for diabetes mellitus.
- Describe the pathophysiology of diabetes, including macrovascular, microvascular, and neuropathic alterations.
- Review the therapeutic regimen for treatment of diabetes, such as insulin and traditional medications.
- Discuss the role of the newer incretin-based therapies in the treatment of diabetes.